Advertisement

Epidemiology of Autoimmune Skin Disorders

  • Berthold Rzany
  • Niels Weller

Keywords

Systemic Lupus Erythematosus Systemic Lupus Erythematosus Patient Systemic Sclerosis Connective Tissue Disease Bullous Pemphigoid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Asboe-Hansen G (1985) Epidemiology of progressive systemic sclerosis in Denmark. In: Black CM, Myers AR (eds) Systemic Sclerosis (Scleroderma). Gower, New York, p 78Google Scholar
  2. Ball C, Sackett D, Phillips B, Haynes B, Straus S (1999) Levels of evidence and grades of recommendationsGoogle Scholar
  3. Bastuji-Garin S, Joly P, Picard-Dahan C, Bernard P, Vaillant L, Pauwels C, Salagnac V, Lok C, Roujeau JC (1996) Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol 132: 272–276CrossRefPubMedGoogle Scholar
  4. Bernard P, Vaillant J, Labeille B, Bedane C, Arbeille B, Denoeux JP et al. (1995) Incidence and distribution of subepidermal bullous skin diseases in three french regions. Arch Dermatol 131:48–52CrossRefPubMedGoogle Scholar
  5. Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie, 4th edn Springer, Berlin Heidelberg New YorkGoogle Scholar
  6. Burns CG (1994) The epidemiology of systemic sclerosis: a population-based case-control study, PhD dissertation (Epidemiological Sciences), University of MichiganGoogle Scholar
  7. Connell EB (1998) The exploitation of autoimmune disease: breast implant litigation and its dire implications for women’s health. J Womens Health 7: 329–338PubMedGoogle Scholar
  8. Cooper GS, Dooley MA, Treadwell EL, St. Clair WE, Gilkeson GS (2001) Smoking and use of hair treatments in relation to risk of developing systemic lupus erythematosus. J Rheumatol 28(12): 2653–2656PubMedGoogle Scholar
  9. Cooper GS, Dooley MA, Treadwell EL, St. Clair EW, Gilkeson GS (2002a) Hormonal and Reproductive Risk Factors for Development of Systemic Lupus Erythematosus. Arthritis Rheum 46: 1830–1839CrossRefPubMedGoogle Scholar
  10. Cooper GS, Dooley MA, Treadwell EL, St. Clair EW, Gilkeson GS (2002b) Risk factors for development of systemic lupus erythematosus: Allergies, infections, and family history. J Clin Epidemiol 55: 982–989CrossRefPubMedGoogle Scholar
  11. Cooper GS, Stroehla BC (2003) The epidemiology of autoimmune diseases. Autoimmun Rev 2:119–125CrossRefPubMedGoogle Scholar
  12. Edworthy SM, Martin L, Barr SG, Birdsell DC, Brant RF, Fritzler MJ (1998) A clinical study of the relationship between silicone breast implants and connective tissue disease. J Rheumatol 25: 254–260PubMedGoogle Scholar
  13. Englert HJ, Brooks P (1994) Scleroderma and augmentation mammoplasty — a causal relationship? Austr NZ J Med 24: 74–80Google Scholar
  14. Englert H, Small-McMahon J, Chambers P, O’Connor H, Davis K, Manolios N, White R, Dracos G, Brooks P (1999a) Familial risk estimation in systemic sclerosis. Aust N Z J Med 29: 36–41PubMedGoogle Scholar
  15. Englert H, Small-McMahon J, Davis K, O’Connor H, Chambers P, Brooks P (1999b) Systemic Sclerosis prevalence and mortality in Sydney 1974–88. Aust NZ J Med 29: 42–50Google Scholar
  16. Fessel WJ (1974) Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptomes; the high prevalence in black women. Arch Intern Medicin 134:1027–1035CrossRefGoogle Scholar
  17. Fujikawa S, Okuni M (1997) A nationwide surveillance study of rheumatic diseases among Japanese children. Acta Paediatr Jpn 39: 242–244PubMedGoogle Scholar
  18. Gabriel SE, O’Fallon WM, Kurland LT, Beard CM, Woods JE, Melton LJ (1994) Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med 330:1697–1702CrossRefPubMedGoogle Scholar
  19. Gallego H, Crutchfield CE, Lewis EJ, Gallego HJ (1999) Report of an association between discoid lupus erythematosus and smoking. Cutis 63: 231–234PubMedGoogle Scholar
  20. Geirsson AJ, Steinsson K, Guthmundsson S, Sigurthsson (1994) Systemic sclerosis in Iceland: A nationwide epidemiological study. Ann Rheum Dis 53: 502–505PubMedGoogle Scholar
  21. Giltay EJ, Moens HJB, Riley AH, Tan RG (1994) Silicone breast protheses and rheumatic symptoms: a retrospective follow-up study. Ann Rheum Dis 53: 194–196PubMedGoogle Scholar
  22. Goldman JA, Greenblatt J, Joines R, White L, Aylward B, Lamm SH (1995) Breast implants, rheumatoid arthritis, and connective tissue diseases in a clinical practice. J Clin Epidemiol 48: 571–582CrossRefPubMedGoogle Scholar
  23. Grattan CEH (1985) Evidence of an association between bullous pemphigoid and psoriasis. Br J Dermatology 113: 281–283Google Scholar
  24. Guillaume JC, Roujeau JC, Touraine R (1984) Systemic lupus after breast prosthesis. Ann Dermatol Venerol 111: 703–704Google Scholar
  25. Gutierrez FJ, Espinoza LR (1990) Progressive systemic sclerosis complicated by severe hypertension: reversal after silicone implant removal. Am J Med 89: 390–392CrossRefPubMedGoogle Scholar
  26. Haga HJ, Haaland P, Haga T (1992) Silicone breast implants and collagen diseases. Tidsskr Nor Laegeforen 112: 763–764PubMedGoogle Scholar
  27. Hammer M, Krippner H (1991) Three cases of chronic polyarthritis after silicon implantation (breast augmentation): causal realtionship? Immun Infekt 19: 62–63PubMedGoogle Scholar
  28. Hennekens CH, Lee IM, Cook NR, Hebert PR, Karlson EW, LaMotte F, Manson JAE, Buring JE (1996) Self-reported breast implants and connective-tissue diseases in female health professionals — A retrospective cohort study. JAMA 275: 616–621PubMedGoogle Scholar
  29. Hochberg MC (1985) The incidence of lupus erythematosus in Baltimore, Maryland 1970–1977. Arthritis Rheum 28: 80–86PubMedGoogle Scholar
  30. Hochberg MC, Perlmutter DL, Medsger TA Jr, Nguyen K, Steen V, Weisman MH, White B, Wigley FM (1996) Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma). Arthritis Rheum 39: 1125–1131PubMedGoogle Scholar
  31. Hopkinson ND, Doherty M, Powell RJ (1993) The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK, 1989–1990. Br J Rheumatol 32: 110–115PubMedGoogle Scholar
  32. Hopkinson ND, Doherty M, Powell RJ (1994) Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann Rheum Dis 53: 675–680PubMedGoogle Scholar
  33. Hopkinson ND, Jenkinson C, Muir KR, Doherty M, Powell RJ (2000) Racial group, socioeconomic status, and the development of persistent proteinuria in systemic lupus erythematosus. Ann Rheum Dis 59: 116–119CrossRefPubMedGoogle Scholar
  34. Jacobson DL, Gange SJ, Rose NR, Graham NMH (1997) Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopath 84: 223–243CrossRefGoogle Scholar
  35. Jick H, Jick SS, Derby LE (1991) Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 302: 766–768PubMedGoogle Scholar
  36. Johnson AE, Cavalcanti FS, Gordon C, Nived O, Palmer RG, Sturfelt G, Viner NJ, Bacon PA (1994) Cross-sectional analysis of the differences between patients with systemic lupus erythematosus in England, Brazil and Sweden. Lupus 3: 501–506PubMedGoogle Scholar
  37. Jung M, Kippes W, Messer G, Zillikens D, Rzany B (1999) Increased risk of bullous pemphigoid in male and very old patients. A population-based study on incidence. J Am Acad Dermatol 41: 266–268PubMedGoogle Scholar
  38. Kaipiainen-Seppänen O, Aho K (1996) Incidence of rare systemic rheumatic and connective tissue diseases in Finland. J Intern MedGoogle Scholar
  39. Kaipiainen-Seppänen O, Savolainen A (1996) Incidence of chronic juvenile rheumatic diseases in Finland during 1980–1990. Clin Exp Rheumatol 14: 441–444PubMedGoogle Scholar
  40. Karlson EW, Daltroy LH, Lew RA, Wright EA, Partridge AJ, Roberts WN, Stern SH, Straaton KV, Wacholtz MC, Grosflam JM et al. (1995) The independence and stability of socioeconomic predictors of morbidity in systemic lupus erythematosus. Arthritis Rheum 38: 267–273PubMedGoogle Scholar
  41. Karlson EW, Daltroy LH, Lew RA, Wright EA, Partridge AJ, Fessel AH, Roberts WN, Stern SH, Straatom KV, Wachotz MC, Kavanaugh AF, Grosflam JM, Liang MH (1997) The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 40: 47–56PubMedGoogle Scholar
  42. Kind P, Goerz G (1987) Klinik und Differentialdiagnose des kutanen Lupus erythematodes. Z Hautkr 62: 1337–1347PubMedGoogle Scholar
  43. Kumagai Y, Shiokawa Y, Medsger TJ, Rodnan GP (1984) Clinical spectrum of CTD after cosmetic surgery. Observations on eighteen patients and review of the Japanese literature. Arthritis Rheum 27: 1–12PubMedGoogle Scholar
  44. Lawrence JS, Martins CL, Drake GL (1987) A family survey of lupus erythematosus. I. Heritability. J Rheumatol 14: 913–921PubMedGoogle Scholar
  45. Lilienfeld DE, Stolley PD (1994) Foundations of Epidemiology 3rd edn Oxford University Press, New York OxfordGoogle Scholar
  46. Maricq HR, Weinrich MC, Keil JE, Smith EA, Harper FE, Nussbaum AI, LeRoy EC, McGregor AR, Diat F, Rosal EJ (1989) Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 32: 998–1002PubMedGoogle Scholar
  47. Marik PE, Kark AL, Zambakides A (1990) Scleroderma after silicone augmentation mammoplasty. A report of 2 cases. S Afr Med J 77: 212–213PubMedGoogle Scholar
  48. Masouyé I, Schmied E, Didierjean I (1998) Bullous pemphigoid and multiple sclerosis: more than a coincidence? J Am Acad Dermatol 21: 63–68Google Scholar
  49. Mayes MD, Lacey JV, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, Schottenfeld D (2003) Prevalence, Incidence, Survival, and Disease Characteristics of Systemic Sclerosis in a Large US Population. Arthritis Rheum 48: 2246–2255CrossRefPubMedGoogle Scholar
  50. Mayes MD, Laing TJ, Gillespie BW et al. (1996) Prevalence, incidence and survival rates of systemic sclerosis in the Detroit metropolitan area. Arthritis Rheum 39: 5150Google Scholar
  51. Meier CR, Sturkenboom MCJM, Cohen AS, Jick H (1998) Postmenopausal Estrogen Replacement Therapy and the Risk of Developin Systemic Lupus Erythematosus or Discoid Lupus. J Rheumatol 25: 1515–1519PubMedGoogle Scholar
  52. Michet CJ Jr, McKenna CH, Elveback LR, Kaslow RA, Kurland LT (1985) Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota,1950 through 1979. Mayo Clin Proc 60: 105–113PubMedGoogle Scholar
  53. Miyoshi K, Miyaoka T, Kobayashi Y, Itakura T, Nishijo K, Higashibara M, Shiragami H, Ohno F (1964) Hypergammaglobulinemia by prolonged adjuvanticity in man: disorders developed after augmentation mammoplasty. Ijishimpo 2122: 9Google Scholar
  54. Molad Y (1987) Clinical manifestations and labaratory data of subacute cutaneous lupus erythematosus. Israel J Med Sci 23: 278–280PubMedGoogle Scholar
  55. Mooney E, Wade TR (1989) Subacute cutaneous lupus erythematosus in Iceland. Int J Dermatol 28: 104–106PubMedGoogle Scholar
  56. Nagata C, Fujita S, Iwata H, Kurosawa Y, Kobayashi K, Kobayashi M, Motegi K, Omura T, Yamamoto M, Nose T, Nakamura K-I, Hashimoto T, Nakamura Y, Yanagawa H (1995) Systemic lupus erythematosus: a case-control epidemiologic study in Japan. Int J Dermatol 34: 333–337PubMedGoogle Scholar
  57. Nyrén O, Yin L, Josefsson S, McLaughlin JK, Blot WJ, Engqvist M, Hakelius L, Boice Jr JD, Adami H-O (1998) Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ 316:417–422PubMedGoogle Scholar
  58. Park AJ, Black RJ, Sarhadi NS, Chetty U, Watson ACH (1997). Silicone gel-filled breast implants and connective tissue disease. Plast Reconstr Surg 101: 261–268Google Scholar
  59. Parks CG, Cooper GS, Nylander-French LA, Sanderson WT, Dement JM, Cohen PL, Dooley MA, Treadwell EL, St. Clair EW, Gilkeson GS, Hoppin JA, Savitz DA (2002) Occupational Exposure to Crystalline Silica and Risk of Systemic Lupus Erythematosus. Arthritis Rheum 46: 1840–1850CrossRefPubMedGoogle Scholar
  60. Pelkonen P, Jalanko H, Lantto RK, Makela AC, Pietikainen MA, Savolainen HA, Verronen PM (1994) Incidence of systemic connective tissue diseases in children: A nationwide prospective study in Finland. J Rheumatol 21: 2143–6PubMedGoogle Scholar
  61. Perkins LL, Clark BD, Klein PJ, Cook RR (1995) A meta-analysis of breast implants and connective tissue disease. Ann Plast Surg 35: 561–570PubMedGoogle Scholar
  62. Peterson LS, Nelson AM, Su WPD, Mason T, O’Fallon M, Gabriel SE (1997) The epidemiology of morphea (localized scleroderma) in Olmsted County 1960–1993. J Rheum 24: 73–80PubMedGoogle Scholar
  63. Pisa FE, Bovenzi M, Romeo L, Tonello A, Biasi D, Bambara LM, Betta A, Barbone F (2002) Reproductive factors and the risk of sclerodermia. An Italian case-control study. Arthritis Rheum 46: 451–456CrossRefPubMedGoogle Scholar
  64. Rzany B, Coresh J, Whelton PK, Petri M (1999) Risk factors for hypercreatinemia in patients with systemic lupus erythematosus (SLE). Lupus 8: 532–540PubMedGoogle Scholar
  65. Rzany B, Danckwardt C, Jung M, Schuhmann M, Messer G, Bayerl C (2000) Erhöhtes Risiko von Malignomerkrankungen mit bullösem Pemphigoid. Akt Dermatol 26: 53–59Google Scholar
  66. Sánchez-Guerrero J, Liang MH, Karlson EW, Hunter DJ, Colditz GA (1995a) Postmenopausal Estrogen Therapy and the Risk for Developing Systemic Lupus Erythematosus. Ann Intern Med 122: 430–433PubMedGoogle Scholar
  67. Sánchez-Guerrero J, Colditz GA, Karlson EW, Hunter DJ, Speizer FE, Liang MH (1995b) Silicone breast implants and the risk of connective-tissue diseases and symptoms. N Engl J Med 332: 1666–1670CrossRefPubMedGoogle Scholar
  68. Schlesselmann JJ (1982) Case-Control Studies: Design, Conduct, Analysis. New York Oxford, Oxford University PressGoogle Scholar
  69. Schusterman MA, Kroll SS, Reece GP, Miller MJ, Ainslie N, Halabi S, Balch CM (1993) Incidence of autoimmune disease in patients after breast reconstruction with silicone gel implants versus autogenous tissue: a preliminary report. Ann Plast Surg 31: 1–6PubMedGoogle Scholar
  70. Shopland DR, Hartman AM, Gibson JT et al. (1996) Cigarette smoking among U.S. adults by state and region: estimates from the current population survey. J Natl Cancer Inst 88: 1748–1758PubMedGoogle Scholar
  71. Siegel M, Lee SL (1973) The epidemiology of systemic lupus erythematosus. Arthritis Rheum 3:1–54CrossRefPubMedGoogle Scholar
  72. Silman A, Jannini S, Symmons D, Bacon P (1988) An epidemiological study of scleroderma in the West Midlands. Br J Rheumatol 27: 286–290PubMedGoogle Scholar
  73. Sontheimer RD, Thomas JR, Gilliam JN (1979) Subacute cutaneous lupus erythematosus — A cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 115: 1409–1415CrossRefPubMedGoogle Scholar
  74. Spiera H (1988) Scleroderma after silicone augmentation mammoplasty. JAMA 260: 236–238CrossRefPubMedGoogle Scholar
  75. Strom BL, Reichenberger MM, West S, Snyder ES, Freundlich B, Stolley PD (1994) Shingles, allergies, family medical history, oral contraceptives, and other potential risk factors for systemic lupus erythematosus. Am J Epidemiol 140: 632–42PubMedGoogle Scholar
  76. Stone SP, Schroeter AL (1975) Bullous Pemphigoid and Malignant Neoplasms. Arch Dermatol 111: 991–994CrossRefPubMedGoogle Scholar
  77. Tamaki T, Mori S, Takehara K (1991) Epidemiological study of patients with systemic sclerosis in Tokyo. Arch Dermatol Res 283: 366–370CrossRefPubMedGoogle Scholar
  78. Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O’Fallon WM, Gabriel SE (1999) Trends in the incidence and mortality of systemic lupus erythematosus, 1950–1992. Arthritis Rheum 42: 46–50CrossRefPubMedGoogle Scholar
  79. Valter I, Saretok S, Maricq HR (1997) Prevalence of Scleroderma Spectrum Disorders in the General Population of Estonia. Scand J Rheumatol 26: 419–425PubMedGoogle Scholar
  80. Van Numen SA, Gatenby PA, Basten A (1982) Postmammoplasty connective tissue disease. Arthritis Rheum 25: 694–697PubMedGoogle Scholar
  81. Venning VA, Wojnarowska F (1990) The association of bullous pemphigoid and malignant disease: a case-control study. Br J Dermatol 123: 439–445PubMedGoogle Scholar
  82. Venning VA, Whitehead PH, Leigh IM, Allen J, Wojnarowska F (1991) The clinical expression of bullous pemphigoid is not determined by the specifity of the target antigen. Br J Dermatol 125: 561–565PubMedGoogle Scholar
  83. Walley T, Mantgani A (1997) The UK General Practice Research Database. Lancet 350: 1097–1099CrossRefPubMedGoogle Scholar
  84. Weinstein C (1987) Lupus and non-lupus cutaneous manifestations in systemic lupus erythematosus. Aust NZ J Med 17: 501–506Google Scholar
  85. Weisman MH, Vecchione TR, Albert D, Moore LT, Mueller MR (1988) CTD following breast augmentation: a preliminary report. Ann Plast Surg 82: 626–630Google Scholar
  86. Wells KE, Cruse CW, Baker JL, Daniels SM, Stern RA, Newman C, Seleznick MJ, Vasey FB, Brozena S, Albers SE, Frenske N (1994) The health status of women following cosmetic surgery. Plast Reconstr Surg 93: 907–912PubMedGoogle Scholar
  87. Wigley FM, Miller R, Hochberg MC, Steen V (1992) Augmentation mammoplasty in patients with systemic sclerosis: data from the Baltimore Scleroderma Research Center and Pittsburgh Scleroderma Data Bank. Arthritis Rheum 35: 65Google Scholar
  88. www.cochrane.org (2000)Google Scholar
  89. Zillikens D, Wever S, Roth A, Weidenthaler-Barth B, Hashimoto T, Bröcker EB (1995) Incidence on autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol 131: 957–958CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 2005

Authors and Affiliations

  • Berthold Rzany
  • Niels Weller

There are no affiliations available

Personalised recommendations